Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

2-O-methyl-phosphorothioate oligonucleotide

EU orphan designation number: EU/3/06/357
Active ingredient: 2-O-methyl-phosphorothioate oligonucleotide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Prosensa B.V.
Einsteinweg 55, NL-2333 CC Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2006 Centralised Orphan - Designation EMEA/OD/096/05 (2006)550 of 16/02/2006
03/03/2009 Centralised Orphan - Removal of orphan designation from Community Register